(HealthDay News) -- Here are the latest clinical trials,
This study will evaluate the safety and effectiveness of an
investigational hormone contraceptive to treat menstrual migraines.
The study will consist of five visits over about 20 weeks.
The research site is in Seattle, Wash.
This study will evaluate a non-invasive device for insomnia. It
will last up to eight weeks, involving two office visits and four
The research site is in Glendale, Calif.
Pulmonary Arterial Hypertension (PAH)
This study is for people with pulmonary arterial hypertension, a
rare and debilitating condition that causes high blood pressure in
lung blood vessels. Symptoms may include shortness of breath,
fatigue, chest pain and rapid heartbeat.
The research site is in Boston, Mass.
ClinicalConnection.com. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.